1. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group;Borasio;Neurology,1998
2. Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women;Butterfield;Am. J. Physiol.,1997
3. Recombinant human insulin-like growth factor I treatment for 1week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance;Cusi;J. Clin. Endocrinol. Metab.,2000
4. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women;Friedlander;J. Clin. Endocrinol. Metab.,2001
5. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group;Lai;Neurology,1997